1,551 kinds of Chinese herbal pieces were newly included in the scope of medical insurance payment. Recently, the Hunan Provincial Medical Insurance Bureau issued a notice (hereinafter referred to as the "Notice") on doing a good job in the implementation of Chinese herbal pieces newly included in the Catalogue of Drugs for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in Hunan Province in 222. The notice mainly includes three aspects: first, it explains the overall situation of newly added Chinese herbal pieces; The second is to clarify the payment standards for the newly added Chinese herbal pieces, including the classification of A and B, the proportion of individual pays, the limited payment scope, and the digestive transition period. The third is to put forward specific requirements for implementation. According to the notice, 551 kinds of traditional Chinese medicine pieces were added this time, which were divided into two parts: "traditional Chinese medicine pieces" and "non-traditional Chinese medicine pieces". Among them, there are 114 kinds of traditional Chinese medicine decoction pieces and 437 kinds of non-traditional Chinese medicine decoction pieces (including 299 kinds of Chinese medicine formula granules and 138 kinds of ultra-micro Chinese medicine decoction pieces). CyberBlue replied "551" in the background to download the Catalogue of Chinese Herbal Pieces Newly Added to the Catalogue of Medicines for Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in Hunan Province in 222. It is worth noting that the self-payment ratio of 551 kinds of Chinese Herbal Pieces added this time is set to , and 353 kinds are fully reimbursed in the medical insurance policy, accounting for 64% of the total number of new pieces, which effectively reduces the self-payment burden of insured patients. In order to meet the diversity of patients' medication, based on the original 892 kinds of traditional Chinese medicine decoction pieces in the national catalogue, Hunan has added 114 kinds of traditional Chinese medicine decoction pieces according to the drug demand and clinical needs. At the same time, on this basis, 299 kinds of traditional Chinese medicine formula granules and 138 kinds of traditional Chinese medicine ultra-micro pieces were added. In order to ensure the continuity of patients' medication, the notice clearly pointed out that 46 kinds of ultra-micro pieces of traditional Chinese medicine originally included in the scope of medical work-related injury and maternity insurance have been included in the scope of this new piece of traditional Chinese medicine, which shall be implemented in accordance with the provisions of this notice. If they are not included in the scope of this new piece of traditional Chinese medicine, the payment date will be December 31, 222, and no payment will be made after the expiration. In addition, the notice clearly stipulates the standard of treatment payment. First, the scope of payment is strictly limited. For 57 traditional Chinese medicine decoction pieces, 139 Chinese medicine formula granules and 72 ultra-micro Chinese medicine decoction pieces, medical insurance for limited compound use has been set up after expert review, and medical insurance will not be paid when used alone; The second is to set the individual pays ratio. The individual pays 2% for 162 Chinese medicine formula granules and 36 ultra-fine pieces of Chinese medicine, which are relatively expensive, which not only meets the demand for drugs, but also effectively guarantees the safety of medical insurance funds. Chinese herbal pieces are expected to expand the market. Chinese herbal pieces are one of the three pillars of Chinese traditional medicine industry. In recent years, under the policies of national basic medicine and national medical insurance, Chinese herbal pieces have developed rapidly. According to the data of Minenet, the market scale of Chinese herbal pieces processing will reach 178.2 billion yuan in 22. In 221, among the 2,86 drugs included in the National Medical Insurance Catalogue, there were 93 ethnic medicines and 892 Chinese herbal pieces. According to relevant statistics, in 221, the total number of Chinese herbal pieces production enterprises in China has reached more than 2,, including 85 enterprises with oral decoction pieces qualification. From the state to the local, Chinese herbal pieces are included in medical insurance. Some people in the industry believe that this is the state's policy to encourage and support the development of Chinese medicine industry, and the dosage of Chinese medicine in hospitals is expected to further increase. On February 11, 222, Gansu Provincial Public Resource Trading Center issued a notice on "Carrying out the work of negotiating and purchasing Chinese herbal pieces in 222", and planned to negotiate and purchase 23 local medicinal materials and key cultivated varieties, such as angelica, codonopsis pilosula, rhubarb, licorice, isatis root, notopterygium root and epimedium, and divide the tablet type requirements and grades of related products. In September, Gansu Provincial Public Resource Trading Center issued a notice on "Publicizing the Supplementary Results of the Fourth Batch of Negotiated Procurement of Chinese Herbal Pieces in 222" (hereinafter referred to as "Supplementary Results of Hanging Nets"), and 993 Chinese herbal products were among them. In the past, the industry generally believed that the main reason for the difficulty in centralized collection of Chinese herbal pieces was that it was difficult to unify the standardization of Chinese herbal pieces, and the prices of related herbal pieces were affected by factors such as seasons and places of origin. Based on this, there is a view in the industry that the standardization of Chinese herbal pieces can be forced through centralized collection. In addition to Gansu, other regions also have related actions. In March of this year, the inter-provincial Chinese herbal medicine purchasing alliance+Sanming purchasing alliance (nationwide) led by Shandong took the lead in launching the centralized collection of Chinese herbal pieces nationwide. 21 common pieces of Radix Astragali, Radix Codonopsis, Flos Lonicerae, Radix Angelicae Sinensis, Flos Carthami, Rhizoma Gastrodiae, Radix Ophiopogonis, Rhizoma Coptidis, Radix Pseudostellariae, Radix Paeoniae Alba, Radix Glycyrrhizae, Lumbricus, Radix Salviae Miltiorrhizae, Radix Scutellariae, Rhizoma Dioscoreae, Herba Taraxaci, Cortex Moutan, and Radix Platycodonis entered the collection list. On May 19th, Anhui Medical Insurance Bureau issued the "Notice on Printing and Distributing the Work Plan for Centralized Purchasing of Pharmaceutical Consumables in Anhui Province in 222", which made it clear that the focus of this year's purchasing work was "unqualified" chemical drugs, biological drugs, Chinese patent medicines and Chinese herbal pieces. On July 3rd, the Office of the Leading Group for Centralized Procurement of Chinese Herbal Pieces in Fenghua District, Ningbo City, Zhejiang Province issued the Implementation Plan for Centralized Procurement of Chinese Herbal Pieces in Public Medical Institutions in Fenghua District, Ningbo City, and announced the centralized procurement of 5 Chinese Herbal Pieces-including common varieties such as Chuanxiong, Radix Rehmanniae, Fructus Trichosanthis, Rhizoma Atractylodis Macrocephalae, Poria, Carthami Flos, Radix Angelicae Sinensis, Fructus Forsythiae, Rhizoma Bletillae, Flos Lonicerae, Radix Astragali and Radix Codonopsis. Judging from the follow-up actions in many places, Chinese herbal pieces have become the category that the field of Chinese herbal medicines was brought into the field of centralized collection earlier after Chinese patent medicines. With the integration of decoction pieces into centralized procurement, the production and procurement of decoction pieces may be centralized, and the procurement channels are also expected to be purified. At the same time, forcing enterprises to do traceability is conducive to the production and circulation of authentic medicinal materials. Some insiders told CyberBlue that Chinese herbal pieces are mainly purchased offline in the form of bidding organized by medical institutions themselves. However, judging from the actions of the recruitment platforms in various provinces in recent days, there are places to explore the standardized hanging of Chinese herbal pieces, the negotiation and procurement of Chinese herbal pieces, and even the centralized collection of Chinese herbal pieces. As the part of Chinese herbal pieces is transferred from offline opaque procurement to more standardized and supervised procurement, this 1 billion market will also usher in a more compliant purchase and sale ecology.